IL83930A0 - Purification of recombinant tumor necrosis factor - Google Patents

Purification of recombinant tumor necrosis factor

Info

Publication number
IL83930A0
IL83930A0 IL83930A IL8393087A IL83930A0 IL 83930 A0 IL83930 A0 IL 83930A0 IL 83930 A IL83930 A IL 83930A IL 8393087 A IL8393087 A IL 8393087A IL 83930 A0 IL83930 A0 IL 83930A0
Authority
IL
Israel
Prior art keywords
purification
necrosis factor
tumor necrosis
recombinant tumor
recombinant
Prior art date
Application number
IL83930A
Other languages
English (en)
Original Assignee
Phillips Petroleum Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phillips Petroleum Co filed Critical Phillips Petroleum Co
Publication of IL83930A0 publication Critical patent/IL83930A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL83930A 1986-10-10 1987-09-17 Purification of recombinant tumor necrosis factor IL83930A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/917,625 US4777242A (en) 1986-10-10 1986-10-10 Purification of recombinant tumor necrosis factor

Publications (1)

Publication Number Publication Date
IL83930A0 true IL83930A0 (en) 1988-02-29

Family

ID=25439072

Family Applications (1)

Application Number Title Priority Date Filing Date
IL83930A IL83930A0 (en) 1986-10-10 1987-09-17 Purification of recombinant tumor necrosis factor

Country Status (9)

Country Link
US (1) US4777242A (xx)
EP (1) EP0263518A3 (xx)
JP (1) JPS63105694A (xx)
AU (1) AU596696B2 (xx)
CA (1) CA1291292C (xx)
DK (1) DK529187A (xx)
IE (1) IE872714L (xx)
IL (1) IL83930A0 (xx)
NO (1) NO874231L (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3828784C1 (xx) * 1988-08-25 1989-12-07 Pharma Biotechnologie Hannover Gmbh, 3000 Hannover, De
US5102789A (en) * 1989-03-15 1992-04-07 The Salk Institute Biotechnology/Industrial Associates, Inc. Production of epideramal growth factor in pichia pastoris yeast cells
US5169936A (en) * 1989-04-14 1992-12-08 Biogen, Inc. Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
DE4331358A1 (de) * 1992-10-12 1994-04-14 Braun Melsungen Ag Verfahren zur quantitativen selektiven Entfernung oder präparativen Gewinnung von Tumor-Nekrose-Faktor (TNF) oder/und Lipopolysacchariden (LPS) aus wäßrigen Flüssigkeiten
EP0702563B1 (en) * 1993-05-27 2003-08-06 EntreMed, Inc. Compositions and methods for treating cancer and hyperproliferative disorders
US5451660A (en) * 1993-12-13 1995-09-19 Genentech, Inc. Method for purifying polypeptides
US5866543A (en) * 1995-06-05 1999-02-02 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5872098A (en) * 1995-06-05 1999-02-16 Corvas International, Inc. Nematode-extracted anticoagulant protein
WO1996012021A2 (en) * 1994-10-18 1996-04-25 Corvas International, Inc. Nematode-extracted serine protease inhibitors and anticoagulant proteins
US5863894A (en) * 1995-06-05 1999-01-26 Corvas International, Inc. Nematode-extracted anticoagulant protein
CA2202351A1 (en) * 1994-10-18 1996-04-25 George Phillip Vlasuk Nematode-extracted serine protease inhibitors and anticoagulant proteins
US5866542A (en) * 1994-10-18 1999-02-02 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5945275A (en) * 1994-10-18 1999-08-31 Corvas International, Inc. Nematode-extracted anticoagulant protein
DE19549420A1 (de) * 1995-04-27 1997-09-18 Braun Melsungen Ag Verfahren zur simultanen extrakorporalen Elimination von Tumor-Nekrose Faktor alpha (TNF alpha) und bakteriellen Lipopolysacchariden (LPS) aus Vollblut oder/und Blutplasma
GB9713412D0 (en) * 1997-06-26 1997-08-27 Delta Biotechnology Ltd Improved protein expression strains
DE60333228D1 (de) 2002-12-02 2010-08-12 Amgen Fremont Inc Gegen den tumor nekrose faktor gerichtete antikörper und deren verwendungen
US7906630B2 (en) * 2004-04-27 2011-03-15 PerkinElmer Heath Sciences, Inc. Method for identifying peptides in a biological sample
CN111086073B (zh) * 2020-01-06 2024-06-11 明珠家具股份有限公司 一种打钉机

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2513124B1 (fr) * 1981-07-21 1989-11-17 Hayashibara Biochem Lab Production et applications du facteur de lyse des cellules-cibles
JPS57140725A (en) * 1981-12-28 1982-08-31 Dainippon Pharmaceut Co Ltd Physiologically active substance having carcinostatic action
US4588585A (en) * 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
GR851626B (xx) * 1984-07-05 1985-11-26 Genentech Inc
DE3426049A1 (de) * 1984-07-14 1986-03-06 Boehringer Ingelheim International GmbH, 6507 Ingelheim Humaner-tumor-nekrose-faktor
JPS61124392A (ja) * 1984-11-22 1986-06-12 Asahi Chem Ind Co Ltd 遺伝子組換体の産生する生理活性物質の精製法
US4677197A (en) * 1985-10-30 1987-06-30 Cetus Corporation Purification method for tumor necrosis factor

Also Published As

Publication number Publication date
EP0263518A2 (en) 1988-04-13
US4777242A (en) 1988-10-11
DK529187A (da) 1988-04-11
NO874231D0 (no) 1987-10-09
AU7817387A (en) 1988-04-14
NO874231L (no) 1988-04-11
IE872714L (en) 1988-04-10
CA1291292C (en) 1991-10-22
JPS63105694A (ja) 1988-05-10
DK529187D0 (da) 1987-10-09
EP0263518A3 (en) 1989-03-15
AU596696B2 (en) 1990-05-10

Similar Documents

Publication Publication Date Title
GB2231265B (en) Therapeutic use of serotonin-antagonists
IL83930A0 (en) Purification of recombinant tumor necrosis factor
GB8615675D0 (en) Purification of hemoglobin
GB8605556D0 (en) Purification of blood coalulation
IL71067A (en) Purification of recombinant interferons
GB2163073B (en) Treatment of pistons
JPS6462323A (en) Purification of polyoxybutylene-polyoxyalkylene glycol
NZ218103A (en) Purification of tissue necrosis factor (tnf)
GB2176688B (en) Heat treatment of slurries
GR860847B (en) Recombinant human renin
GB2186580B (en) Purification of recombinant human interleukin-la
ZA866582B (en) Recombinant virus
GB8619667D0 (en) Heat treatment of slurries
ZA857906B (en) Human tumor necrosis factor
ZA841395B (en) Purification of interferon
GB8728975D0 (en) Purification of recombinant protein
GB2174381B (en) Manufacture of aggregate
NZ216207A (en) Purification of 5-pyrimidinecarboxamides
IE860059L (en) Purification of polypeptides
GB8828726D0 (en) Purification of recombinant protein
GB8420544D0 (en) Treatment of pistons
PH20858A (en) Treatment of aluminous materials
GB8518352D0 (en) Treatment of electron-resist
GB8429852D0 (en) Heat treatment of slurries
ZA855059B (en) Tumor necrosis factor

Legal Events

Date Code Title Description
EXP Patent expired